The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.
about
Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies.Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence.Tolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review.2012 update: guidelines for adult urinary incontinence collaborative consensus document for the canadian urological associationActivation of bitter taste receptors (tas2rs) relaxes detrusor smooth muscle and suppresses overactive bladder symptomsEfficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial.Further evidence of endogenous hydrogen sulphide as a mediator of relaxation in human and rat bladder.Current pharmacological treatment options for male lower urinary tract symptoms.What do we know and not know about mirabegron, a novel β3 agonist, in the treatment of overactive bladder?Non-Hormonal treatment of BPH/BOOCurrent role of treatment in men with lower urinary tract symptoms combined with overactive bladder.Measurement of post-void residual urine.Tolterodine in the Treatment of Male LUTS.Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia.The efficacy and safety of combined therapy with α-blockers and anticholinergics for men with benign prostatic hyperplasia: a meta-analysis.Short-term Effect of Tamsulosin and Finasteride Monotherapy and their Combination on Nigerian Men with Benign Prostatic Hyperplasia.Mirabegron for male lower urinary tract symptoms.[Combination therapy of benign prostate syndrome/lower urinary tract symptoms].Muscarinic receptor subtype mRNA expression in the human prostate: association with age, pathological diagnosis, prostate size, or potentially interfering medications?Therapeutic effect of α-blockers and antimuscarinics in male lower urinary tract symptoms based on the International Prostate Symptom Score subscore ratio.
P2860
Q33727733-618D53E7-EFBB-40AA-B4B6-A6C90E08FDB7Q34405906-2C5F0D99-486B-45F4-B13F-C6C02E252FBAQ34502903-1B5ACBB0-949C-43C5-A143-793A0580DE38Q36338816-9C8A00AA-CDFC-4CF3-B19C-C6E82D4F1286Q37225238-06AA69AF-6641-4839-97EF-70D00D210CA9Q37279662-2ECED2C5-8782-42A0-ADF0-415B2FDF314DQ37437017-28224AAF-2C74-4FA7-9B73-562C9E5D7A6AQ38103891-6054BA5A-23DB-4762-BE75-8BFAAC7B99FBQ38127144-5B7877F4-4D45-4D75-B401-749399D81C53Q38205423-2C581F32-ACC8-420F-8B15-AC1B8BB6FFB8Q38230461-59528006-276F-4D93-AC5B-03C38270846BQ38253841-26E273E0-ECB5-4C18-B508-5FACC183BA32Q38543432-BCB687E7-6510-4F1D-8151-5E83564BD90DQ41154385-115734C1-6728-4C2F-A738-E57FD2C2AD30Q41858052-25311EA8-696F-40B9-9455-D4C15572959EQ42250171-E0419B53-6746-45B7-9CBE-8845ACCC0B85Q44522571-D0330DF7-B31D-412F-92DC-A15516AC1B48Q46199971-2BD579A5-8EF9-4358-AC20-9DA0123B5D32Q47201533-7507CC0E-4C42-4CA3-A794-721E4084D7BEQ53137219-B3249B95-C970-44E8-AC83-B862A4239EAE
P2860
The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of antimuscarinics in ...... outlet obstruction: an update.
@en
The role of antimuscarinics in ...... outlet obstruction: an update.
@nl
type
label
The role of antimuscarinics in ...... outlet obstruction: an update.
@en
The role of antimuscarinics in ...... outlet obstruction: an update.
@nl
prefLabel
The role of antimuscarinics in ...... outlet obstruction: an update.
@en
The role of antimuscarinics in ...... outlet obstruction: an update.
@nl
P2093
P50
P1433
P1476
The role of antimuscarinics in ...... outlet obstruction: an update.
@en
P2093
Andrea Tubaro
Christian Gratzke
Clare Fowler
Steven Kaplan
P304
P356
10.1016/J.EURURO.2011.03.054
P407
P577
2011-04-09T00:00:00Z